If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWetherspoon (J.D) Share News (JDW)

Share Price Information for Wetherspoon (J.D) (JDW)

Share Price is delayed by 15 minutes
Get Live Data
718.50    0.00 (0.00%)
Bid:
712.50
Ask:
715.50
Spread: 3.00 (0.421%)
Market Cap: £757.34m
JDW Live PriceLast checked at - London Stock Exchange

Intraday Wetherspoon (J.D) Share Chart

Friday broker round-up

Fri, 15th Nov 2019 13:09
(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

Tyman: Liberum reiterates buy with a target price of 300p.

Experian: Deutsche Bank upgrades to hold with a target price of 2,200p.

Burberry: Deutsche Bank reiterates hold with a target price of 2,010p.

AstraZeneca: Liberum Capital reiterates buy with a target price of 8,250p.

GlaxoSmithKline: Jefferies reiterates buy with a target price of 1,850p.

Workspace: Berenberg downgrades to sell with a target price of 950p.

Berkeley Group: Goldman Sachs downgrades to sell with a target price of 3,860p.

Burberry: Credit Suisse reiterates outperform with a target price of 2,700p.

Genus: Jefferies initiates hold with a target price of 3,272p.

Wetherspoon: Barclays reiterates overweight with a target price of 1,690p.

RHI Magnesita: Barclays reiterates overweight with a target price of 4,400p.

Ted Baker: RBC Capital Markets reiterates sector performer with a target price of 440p

Related News

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
13 hours ago

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...

Hutchmed drug approved in China for advanced gastric cancer
15 hours ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

Wetherspoon (J.D) News

UK's Mitchells & Butlers says softer spending hits sales, shares fall
21 May 2026

UK's Mitchells & Butlers says softer spending hits sales, shares fall

* Second-quarter sales growth slows to 1.8%, further easing to ​1.1% recently

GRAPHIC-Europe first-quarter earnings: Energy is a boom for growth but a bust for consumers 
13 May 2026

GRAPHIC-Europe first-quarter earnings: Energy is a boom for growth but a bust for consumers 

* European earnings set to grow at fastest pace in three years

LONDON MARKET MIDDAY: US and Iran reportedly closer to peace deal
6 May 2026

LONDON MARKET MIDDAY: US and Iran reportedly closer to peace deal

(Alliance News) - Stock prices in London were firmly in the green at midday on Wednesday, as the US and Iran reportedly draw closer to a permanent cea...

Wetherspoon flags third profit warning as costs bite and growth slows 
6 May 2026

Wetherspoon flags third profit warning as costs bite and growth slows 

* Wetherspoon's year-to-date like-for-like sales up 4.3%

JD Wetherspoon quarterly sales rise but costs to cause profit miss
6 May 2026

JD Wetherspoon quarterly sales rise but costs to cause profit miss

(Alliance News) - JD Wetherspoon PLC on Wednesday reported higher quarterly sales but cautioned that higher costs may lead to slightly lower-than-expe...

Wetherspoons warns on profits, cites higher costs
6 May 2026

Wetherspoons warns on profits, cites higher costs

(Sharecast News) - Pub group Wetherspoons warned on profits again on Wednesday as it pointed to higher costs.

LONDON BRIEFING: Next increases profit outlook as sales beat forecast
6 May 2026

LONDON BRIEFING: Next increases profit outlook as sales beat forecast

(Alliance News) - The FTSE 100 was called higher on Wednesday, after US President Donald Trump paused his 'Project Freedom', the military operation to...